Regeneron Pharmaceuticals Inc
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.83 | 9.58 | 13.14 | 3.07 | 11.11 | 11.10 | 9.40 | 10.54 | 15.10 | 10.89 | 10.02 | 5.38 | 41.60 | |
| 0.93 | 0.99 | 0.99 | 1.05 | 1.05 | 1.11 | 1.14 | 1.24 | 1.28 | 1.35 | 1.14 | 1.16 | 4.95 | |
| 1.80 | 2.11 | 2.00 | 1.93 | 1.94 | 2.67 | 2.30 | 2.32 | 2.21 | 2.32 | 2.39 | 2.28 | 9.24 | |
| -1.70 | -0.54 | 3.83 | -7.87 | 4.03 | -0.76 | 1.17 | -2.10 | 5.83 | 0.05 | -0.72 | -1.51 | 3.67 | |
| 1.55 | 2.75 | 1.41 | 1.83 | 1.58 | 2.35 | 2.44 | 1.63 | 1.88 | 2.31 | 2.14 | 2.25 | 8.62 | |
| -4.38 | -0.58 | -14.66 | -4.83 | -4.94 | 3.08 | 5.82 | -10.07 | -3.76 | 2.05 | -3.98 | -0.87 | -6.59 | |
| – | – | 0.00 | 0.00 | – | – | 0.84 | 0.85 | 0.85 | 0.86 | 0.91 | 0.91 | 3.54 | |
| -5.96 | -6.57 | -2.53 | -5.23 | -6.33 | -8.55 | -9.40 | -9.77 | -6.19 | -6.25 | -7.38 | -10.95 | -30.89 | |
| -3.59 | -3.92 | 0.41 | -4.14 | -5.46 | -9.98 | -9.79 | -10.39 | -6.70 | -7.26 | -7.45 | -21.96 | -43.49 | |
| 1.86 | 5.08 | -1.11 | -5.91 | 0.72 | 4.19 | 5.43 | -9.92 | 4.64 | 5.68 | -1.42 | -17.45 | -8.50 | |
| 8.27 | 6.82 | 11.74 | 1.24 | 9.53 | 8.75 | 6.96 | 8.91 | 13.22 | 8.58 | 7.88 | 3.13 | 32.98 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.